{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:16:30Z","timestamp":1794406590816,"version":"4.9.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T00:00:00Z","timestamp":1451865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/nm.4017","type":"journal-article","created":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T11:48:49Z","timestamp":1451908129000},"page":"175-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":746,"title":["CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress\u2013induced myocardial necroptosis"],"prefix":"10.1038","volume":"22","author":[{"given":"Ting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1701-2548","authenticated-orcid":false,"given":"Mingyao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxiang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibao","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Mei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Ping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,4]]},"reference":[{"key":"BFnm4017_CR1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/CIRCRESAHA.110.225730","volume":"108","author":"G Kung","year":"2011","unstructured":"Kung, G., Konstantinidis, K. & Kitsis, R.N. Programmed necrosis, not apoptosis, in the heart. Circ. Res. 108, 1017\u20131036 (2011).","journal-title":"Circ. Res."},{"key":"BFnm4017_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.physiol.010908.163111","volume":"72","author":"RS Whelan","year":"2010","unstructured":"Whelan, R.S., Kaplinskiy, V. & Kitsis, R.N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu. Rev. Physiol. 72, 19\u201344 (2010).","journal-title":"Annu. Rev. Physiol."},{"key":"BFnm4017_CR3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","volume":"137","author":"YS Cho","year":"2009","unstructured":"Cho, Y.S. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112\u20131123 (2009).","journal-title":"Cell"},{"key":"BFnm4017_CR4","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-\u03b1. Cell 137, 1100\u20131111 (2009).","journal-title":"Cell"},{"key":"BFnm4017_CR5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/science.1172308","volume":"325","author":"DW Zhang","year":"2009","unstructured":"Zhang, D.W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332\u2013336 (2009).","journal-title":"Science"},{"key":"BFnm4017_CR6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature09857","volume":"471","author":"WJ Kaiser","year":"2011","unstructured":"Kaiser, W.J. et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368\u2013372 (2011).","journal-title":"Nature"},{"key":"BFnm4017_CR7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature09852","volume":"471","author":"A Oberst","year":"2011","unstructured":"Oberst, A. et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363\u2013367 (2011).","journal-title":"Nature"},{"key":"BFnm4017_CR8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.chom.2010.03.006","volume":"7","author":"JW Upton","year":"2010","unstructured":"Upton, J.W., Kaiser, W.J. & Mocarski, E.S. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7, 302\u2013313 (2010).","journal-title":"Cell Host Microbe"},{"key":"BFnm4017_CR9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.chom.2012.01.016","volume":"11","author":"JW Upton","year":"2012","unstructured":"Upton, J.W., Kaiser, W.J. & Mocarski, E.S. DAI\/ZBP1\/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11, 290\u2013297 (2012).","journal-title":"Cell Host Microbe"},{"key":"BFnm4017_CR10","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.26200","volume":"57","author":"S Roychowdhury","year":"2013","unstructured":"Roychowdhury, S., McMullen, M.R., Pisano, S.G., Liu, X. & Nagy, L.E. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 57, 1773\u20131783 (2013).","journal-title":"Hepatology"},{"key":"BFnm4017_CR11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213\u2013227 (2012).","journal-title":"Cell"},{"key":"BFnm4017_CR12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature10273","volume":"477","author":"PS Welz","year":"2011","unstructured":"Welz, P.S. et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477, 330\u2013334 (2011).","journal-title":"Nature"},{"key":"BFnm4017_CR13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/cvr\/cvu146","volume":"103","author":"M Luedde","year":"2014","unstructured":"Luedde, M. et al. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc. Res. 103, 206\u2013216 (2014).","journal-title":"Cardiovasc. Res."},{"key":"BFnm4017_CR14","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1073\/pnas.1200012109","volume":"109","author":"J Zhao","year":"2012","unstructured":"Zhao, J. et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc. Natl. Acad. Sci. USA 109, 5322\u20135327 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4017_CR15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/cdd.2014.126","volume":"22","author":"F Humphries","year":"2015","unstructured":"Humphries, F., Yang, S., Wang, B. & Moynagh, P.N. RIP kinases: key decision makers in cell death and innate immunity. Cell Death Differ. 22, 225\u2013236 (2015).","journal-title":"Cell Death Differ."},{"key":"BFnm4017_CR16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/cr.2013.91","volume":"23","author":"J Wu","year":"2013","unstructured":"Wu, J. et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res. 23, 994\u20131006 (2013).","journal-title":"Cell Res."},{"key":"BFnm4017_CR17","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1172\/JCI31060","volume":"117","author":"H Nakayama","year":"2007","unstructured":"Nakayama, H. et al. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J. Clin. Invest. 117, 2431\u20132444 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnm4017_CR18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/187152508785909474","volume":"6","author":"AL Ferreira","year":"2008","unstructured":"Ferreira, A.L., Matsubara, L.S. & Matsubara, B.B. Anthracycline-induced cardiotoxicity. Cardiovasc. Hematol. Agents Med. Chem. 6, 278\u2013281 (2008).","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"BFnm4017_CR19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM199809243391307","volume":"339","author":"PK Singal","year":"1998","unstructured":"Singal, P.K. & Iliskovic, N. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339, 900\u2013905 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnm4017_CR20","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","volume":"53","author":"ET Yeh","year":"2009","unstructured":"Yeh, E.T. & Bickford, C.L. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J. Am. Coll. Cardiol. 53, 2231\u20132247 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnm4017_CR21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","volume":"57","author":"DA Gewirtz","year":"1999","unstructured":"Gewirtz, D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57, 727\u2013741 (1999).","journal-title":"Biochem. Pharmacol."},{"key":"BFnm4017_CR22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti, G., Menna, P., Salvatorelli, E., Cairo, G. & Gianni, L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56, 185\u2013229 (2004).","journal-title":"Pharmacol. Rev."},{"key":"BFnm4017_CR23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev, A. et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4, 313\u2013321 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"BFnm4017_CR24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10557-007-6035-1","volume":"21","author":"CC Smith","year":"2007","unstructured":"Smith, C.C. et al. Necrostatin: a potentially novel cardioprotective agent? Cardiovasc. Drugs Ther. 21, 227\u2013233 (2007).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"BFnm4017_CR25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10557-007-6067-6","volume":"21","author":"SY Lim","year":"2007","unstructured":"Lim, S.Y., Davidson, S.M., Mocanu, M.M., Yellon, D.M. & Smith, C.C. The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore. Cardiovasc. Drugs Ther. 21, 467\u2013469 (2007).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"BFnm4017_CR26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00395-012-0270-8","volume":"107","author":"MI Oerlemans","year":"2012","unstructured":"Oerlemans, M.I. et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Res. Cardiol. 107, 270 (2012).","journal-title":"Basic Res. Cardiol."},{"key":"BFnm4017_CR27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","volume":"54","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell 54, 133\u2013146 (2014).","journal-title":"Mol. Cell"},{"key":"BFnm4017_CR28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cardiores.2006.12.003","volume":"73","author":"M Vila-Petroff","year":"2007","unstructured":"Vila-Petroff, M. et al. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc. Res. 73, 689\u2013698 (2007).","journal-title":"Cardiovasc. Res."},{"key":"BFnm4017_CR29","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCRESAHA.112.276915","volume":"112","author":"H Ling","year":"2013","unstructured":"Ling, H. et al. Ca2+\/calmodulin-dependent protein kinase II \u03b4 mediates myocardial ischemia\/reperfusion injury through nuclear factor-\u03baB. Circ. Res. 112, 935\u2013944 (2013).","journal-title":"Circ. Res."},{"key":"BFnm4017_CR30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature11444","volume":"491","author":"ML Joiner","year":"2012","unstructured":"Joiner, M.L. et al. CaMKII determines mitochondrial stress responses in heart. Nature 491, 269\u2013273 (2012).","journal-title":"Nature"},{"key":"BFnm4017_CR31","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/nm.2506","volume":"17","author":"BJ He","year":"2011","unstructured":"He, B.J. et al. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat. Med. 17, 1610\u20131618 (2011).","journal-title":"Nat. Med."},{"key":"BFnm4017_CR32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nm1215","volume":"11","author":"R Zhang","year":"2005","unstructured":"Zhang, R. et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat. Med. 11, 409\u2013417 (2005).","journal-title":"Nat. Med."},{"key":"BFnm4017_CR33","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1074\/jbc.M611507200","volume":"282","author":"W Zhu","year":"2007","unstructured":"Zhu, W. et al. Activation of CaMKII\u03b4C is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J. Biol. Chem. 282, 10833\u201310839 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnm4017_CR34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI200316326","volume":"111","author":"WZ Zhu","year":"2003","unstructured":"Zhu, W.Z. et al. Linkage of \u03b21-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+\/calmodulin kinase II. J. Clin. Invest. 111, 617\u2013625 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnm4017_CR35","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.RES.0000069686.31472.C5","volume":"92","author":"T Zhang","year":"2003","unstructured":"Zhang, T. et al. The \u03b4C isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ. Res. 92, 912\u2013919 (2003).","journal-title":"Circ. Res."},{"key":"BFnm4017_CR36","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI38022","volume":"119","author":"H Ling","year":"2009","unstructured":"Ling, H. et al. Requirement for Ca2+\/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J. Clin. Invest. 119, 1230\u20131240 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnm4017_CR37","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1152\/physrev.00018.2010","volume":"91","author":"JR Erickson","year":"2011","unstructured":"Erickson, J.R., He, B.J., Grumbach, I.M. & Anderson, M.E. CaMKII in the cardiovascular system: sensing redox states. Physiol. Rev. 91, 889\u2013915 (2011).","journal-title":"Physiol. Rev."},{"key":"BFnm4017_CR38","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature03434","volume":"434","author":"CP Baines","year":"2005","unstructured":"Baines, C.P. et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658\u2013662 (2005).","journal-title":"Nature"},{"key":"BFnm4017_CR39","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nature03317","volume":"434","author":"T Nakagawa","year":"2005","unstructured":"Nakagawa, T. et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652\u2013658 (2005).","journal-title":"Nature"},{"key":"BFnm4017_CR40","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1161\/CIRCRESAHA.112.265942","volume":"111","author":"C Brenner","year":"2012","unstructured":"Brenner, C. & Moulin, M. Physiological roles of the permeability transition pore. Circ. Res. 111, 1237\u20131247 (2012).","journal-title":"Circ. Res."},{"key":"BFnm4017_CR41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","volume":"87","author":"G Kroemer","year":"2007","unstructured":"Kroemer, G., Galluzzi, L. & Brenner, C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99\u2013163 (2007).","journal-title":"Physiol. Rev."},{"key":"BFnm4017_CR42","doi-asserted-by":"crossref","first-page":"20054","DOI":"10.1073\/pnas.1116302108","volume":"108","author":"S He","year":"2011","unstructured":"He, S., Liang, Y., Shao, F. & Wang, X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl. Acad. Sci. USA 108, 20054\u201320059 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4017_CR43","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2008.02.048","volume":"133","author":"JR Erickson","year":"2008","unstructured":"Erickson, J.R. et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133, 462\u2013474 (2008).","journal-title":"Cell"},{"key":"BFnm4017_CR44","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1074\/jbc.M109.071332","volume":"285","author":"Q Li","year":"2010","unstructured":"Li, Q. et al. Receptor interacting protein 3 suppresses vascular smooth muscle cell growth by inhibition of the phosphoinositide 3-kinase-Akt axis. J. Biol. Chem. 285, 9535\u20139544 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnm4017_CR45","doi-asserted-by":"crossref","first-page":"16871","DOI":"10.1074\/jbc.274.24.16871","volume":"274","author":"X Sun","year":"1999","unstructured":"Sun, X. et al. RIP3, a novel apoptosis-inducing kinase. J. Biol. Chem. 274, 16871\u201316875 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnm4017_CR46","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/lsm.21088","volume":"43","author":"I Coupienne","year":"2011","unstructured":"Coupienne, I., Fettweis, G. & Piette, J. RIP3 expression induces a death profile change in U2OS osteosarcoma cells after 5-ALA-PDT. Lasers Surg. Med. 43, 557\u2013564 (2011).","journal-title":"Lasers Surg. Med."},{"key":"BFnm4017_CR47","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1128\/MCB.19.10.6500","volume":"19","author":"NJ Pazdernik","year":"1999","unstructured":"Pazdernik, N.J., Donner, D.B., Goebl, M.G. & Harrington, M.A. Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-\u03baB. Mol. Cell. Biol. 19, 6500\u20136508 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm4017_CR48","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1101\/gad.223321.113","volume":"27","author":"K Moriwaki","year":"2013","unstructured":"Moriwaki, K. & Chan, F.K. RIP3: a molecular switch for necrosis and inflammation. Genes Dev. 27, 1640\u20131649 (2013).","journal-title":"Genes Dev."},{"key":"BFnm4017_CR49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mito.2010.06.001","volume":"11","author":"D Montaigne","year":"2011","unstructured":"Montaigne, D. et al. Doxorubicin induces mitochondrial permeability transition and contractile dysfunction in the human myocardium. Mitochondrion 11, 22\u201326 (2011).","journal-title":"Mitochondrion"},{"key":"BFnm4017_CR50","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.taap.2010.01.006","volume":"244","author":"D Montaigne","year":"2010","unstructured":"Montaigne, D. et al. Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart. Toxicol. Appl. Pharmacol. 244, 300\u2013307 (2010).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"BFnm4017_CR51","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.yjmcc.2009.12.015","volume":"48","author":"MA Salas","year":"2010","unstructured":"Salas, M.A. et al. The signalling pathway of CaMKII-mediated apoptosis and necrosis in the ischemia\/reperfusion injury. J. Mol. Cell. Cardiol. 48, 1298\u20131306 (2010).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnm4017_CR52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.carpath.2005.03.006","volume":"14","author":"LM Buja","year":"2005","unstructured":"Buja, L.M. Myocardial ischemia and reperfusion injury. Cardiovasc. Pathol. 14, 170\u2013175 (2005).","journal-title":"Cardiovasc. Pathol."},{"key":"BFnm4017_CR53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy, D.J. & Yellon, D.M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 123, 92\u2013100 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnm4017_CR54","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1161\/CIRCULATIONAHA.110.954628","volume":"121","author":"CM Cao","year":"2010","unstructured":"Cao, C.M. et al. MG53 constitutes a primary determinant of cardiac ischemic preconditioning. Circulation 121, 2565\u20132574 (2010).","journal-title":"Circulation"},{"key":"BFnm4017_CR55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/CIRCRESAHA.109.210914","volume":"106","author":"W Peng","year":"2010","unstructured":"Peng, W. et al. Cardioprotection by CaMKII-\u03b4B is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70. Circ. Res. 106, 102\u2013110 (2010).","journal-title":"Circ. Res."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.4017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4017","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:54:41Z","timestamp":1684436081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.4017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,4]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFnm4017"],"URL":"https:\/\/doi.org\/10.1038\/nm.4017","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726054536.793516537","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,4]]},"assertion":[{"value":"7 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}